1-6 of 6
A. Torres, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Lenalidomide on Hepatitis C Viremia in Cancer Patients: A Case Series

Jeff Hosry, MD, Felipe Samaniego, MD, Francesco Turturro, MD, Minas P. Economides, MD, Harrys A. Torres, MD
Journal: Blood
Blood (2016) 128 (22): 5691.
https://doi.org/10.1182/blood.V128.22.5691.5691
Published: 2016
Journal Articles

Incidence and Management of Hematological Toxicities Associated with Treatment of Hepatitis C Virus Infection in Cancer Patients

Andreas Kyvernitakis, MD, Thein H. Oo, MD FACP, FRCP, Michael H. Kroll, MD, Vahid Afshar-Kharghan, MD, Parag Mahale, MBBS, MPH, Harrys A. Torres, MD FACP
Journal: Blood
Blood (2014) 124 (21): 4126.
https://doi.org/10.1182/blood.V124.21.4126.4126
Published: 2014
Journal Articles

The Effect of Different Rituximab-Containing Chemotherapy Strategies on Hepatitis C Viremia

Parag Mahale, MBBS, MPH, Francesco Turturro, MD, Jorge Romaguera, MD, Nathan Fowler, MD, Harrys A. Torres, MD FACP
Journal: Blood
Blood (2014) 124 (21): 4448.
https://doi.org/10.1182/blood.V124.21.4448.4448
Published: 2014
Journal Articles

Development of Non-Hodgkin’s Lymphoma As Second Primary Cancer in Hepatitis C Virus-Infected Patients with a Different Primary Malignancy – a Case Series

Parag Mahale, MBBS, MPH, Jorge Romaguera, MD, Francesco Turturro, MD, Nathan Fowler, MD, Harrys A. Torres, MD FACP
Journal: Blood
Blood (2014) 124 (21): 5414.
https://doi.org/10.1182/blood.V124.21.5414.5414
Published: 2014
Journal Articles

Use of Growth Factors in Treatment of Hepatitis C Viral Infection in Cancer Patients

Harrys A. Torres, MD, FACP, Parag Mahale, MBBS, MPH, Abhinav Saxena, MBBS, Vahid Afshar-Kharghan, MD, Michael H. Kroll, MD, Thein H Oo, MD, FACP, FRCP
Journal: Blood
Blood (2012) 120 (21): 4725.
https://doi.org/10.1182/blood.V120.21.4725.4725
Published: 2012
Journal Articles

Voriconazole in Primary Prophylaxis Reduces the Incidence of IFI in High Risk Hematologic Patients.

R. Rojas, MD, J. Serrano, MD, C. Martin, MD, S. Tabares, M. Capote, M. Fernandez, V. Arqueros, J. R. Molina D, V. Martin, A. Torres, MD
Journal: Blood
Blood (2005) 106 (11): 5349.
https://doi.org/10.1182/blood.V106.11.5349.5349
Published: 2005